NERV

Minerva Neurosciences Inc (NERV)

About Minerva Neurosciences Inc (NERV)

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Details

Daily high

$2.69

Daily low

$2.60

Price at open

$2.66

52 Week High

$13.49

52 Week Low

$2.26

Market cap

18.3M

Dividend yield

0.00%

Volume

12,509

Avg. volume

11,817

P/E ratio

-.59

Minerva Neurosciences Inc News